Clinical Cancer Research CR Helping Patients Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, S. V.
Right arrow Articles by Spivack, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, S. V.
Right arrow Articles by Spivack, S. D.
Clinical Cancer Research Vol. 12, 5033-5039, September 1, 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Validity of Messenger RNA Expression Analyses of Human Saliva

Shalini V. Kumar1, Gregory J. Hurteau2 and Simon D. Spivack1,3,4

Authors' Affiliations: 1 Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Albany, New York, 2 Ordway Research Institute, 3 Pulmonary and Critical Care Medicine, Albany Medical College, Albany, New York, and 4 Environmental Health Sciences, School of Public Health, State University of New York, Rensselaer, New York

Requests for reprints: Simon D. Spivack, Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, P.O. Box 509, Empire State Plaza, Albany, NY 12201-0509. Phone: 518-473-0782; Fax: 518-486-1505; E-mail: spivack{at}wadsworth.org.

Purpose: The origins of expression microarray and reverse transcription-PCR (RT-PCR) signals in human saliva were evaluated.

Experimental Design: The "RNA" extracts from human saliva samples were treated with vehicle, DNase, or RNase. Two-step amplification and hybridization to Affymetrix 133A cDNA microarrays were then done. Confirmatory RT-PCR experiments used conventionally designed PCR primer pairs for the reference housekeeper transcripts encoding 36B4, ß-actin, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA sequences, which are known to be homologous to genomic DNA pseudogene sequences. Negative controls included the omission of reverse transcriptase ("no-RT") to detect any DNA-derived signal. Finally, an RNA-specific RT-PCR strategy eliminated confounding signals from contaminating genomic DNA.

Results: Microarray experiments revealed that untreated, DNase-treated, and RNase-treated "RNA" extracts from saliva all yielded negligible overall signals. Specific microarray signals for 36B4, ß-actin, and GAPDH were low, and were unaffected by RNase. Real-time quantitative RT-PCR reactions using conventional, non–RNA-specific primers on saliva samples yielded PCR products for 36B4, ß-actin, and GAPDH; DNase-treated saliva samples did not yield a PCR product, and the "no-RT" and "+RT" conditions yielded similar amounts of PCR product. The RNA-specific RT-PCR strategy, across all conditions, yielded no PCR product from saliva.

Conclusions: The combination of (a) a minimal microarray signal, which was unaffected by RNase treatment, (b) the presence of a conventional RT-PCR housekeeper product in both RNase-treated and no-RT saliva samples, (c) the absence of a conventional RT-PCR housekeeper product in DNase-treated conditions, and (d) the absence of a RNA-specific RT-PCR product shows that any microarray or RT-PCR signal in the saliva must arise from genomic DNA, not RNA. Thus, saliva extracts do not support mRNA expression studies.




This article has been cited by other articles:


Home page
Clin. Chem.Home page
Z. Hu, B. G. Zimmermann, H. Zhou, J. Wang, B. S. Henson, W. Yu, D. Elashoff, G. Krupp, and D. T. Wong
Exon-Level Expression Profiling: A Comprehensive Transcriptome Analysis of Oral Fluids
Clin. Chem., May 1, 2008; 54(5): 824 - 832.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Rani, M. Clynes, and L. O'Driscoll
Detection of Amplifiable mRNA Extracellular to Insulin-Producing Cells: Potential for Predicting Beta Cell Mass and Function
Clin. Chem., November 1, 2007; 53(11): 1936 - 1944.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ballantyne
Validity of Messenger RNA Expression Analyses of Human Saliva
Clin. Cancer Res., February 15, 2007; 13(4): 1350 - 1350.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. D. Spivack

Clin. Cancer Res., February 15, 2007; 13(4): 1351 - 1351.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. T. Wong
Salivary Transcriptome
Clin. Cancer Res., February 15, 2007; 13(4): 1350 - 1350.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.